PAYLEAN 20 DIN 02268973
Status: Dormant
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | RACTOPAMINE HYDROCHLORIDE 20 G |
|---|
| Dosage form | Drug Premix |
|---|
| Route | Oral |
|---|
| Schedule | NON-PRESCRIPTION DRUGS |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 08-Nov-2005 |
|---|
| Current status date | 19-Jul-2019 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RACTOPAMINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02535823 | OPTIGRID | HUVEPHARMA EOOD | Drug Premix | RACTOPAMINE HYDROCHLORIDE 100 G | Approved |
| 02446723 | RACTOPAMINE 100 | BIO AGRI MIX LP | Drug Premix | RACTOPAMINE HYDROCHLORIDE 100 G | Marketed |
| 02471841 | RACTOPAMINE 20 | BIO AGRI MIX LP | Drug Premix | RACTOPAMINE HYDROCHLORIDE 20 G | Approved |
| 02472090 | RACTOPAMINE 4 | BIO AGRI MIX LP | Drug Premix | RACTOPAMINE HYDROCHLORIDE 4 G | Marketed |
| 02426242 | ACTOGAIN 100 | PHIBRO ANIMAL HEALTH CORPORATION | Drug Premix | RACTOPAMINE HYDROCHLORIDE 100 G | Dormant |
| 02426447 | ENGAIN 20 | ZOETIS CANADA INC | Drug Premix | RACTOPAMINE HYDROCHLORIDE 20 G | Cancelled Post Market |
| 02295091 | OPTAFLEXX 100 | ELANCO CANADA LIMITED | Drug Premix | RACTOPAMINE HYDROCHLORIDE 100 G | Cancelled Post Market |
| 02268965 | PAYLEAN 100 | ELANCO CANADA LIMITED | Drug Premix | RACTOPAMINE HYDROCHLORIDE 100 G | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 20141 | 2017-12-08 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 11350 | 2010-05-05 | Supplement to a New Drug Submission (SNDS) | Additional indications |
| 7212 | 2005-07-05 | New Drug Submission (NDS) | |
Request a quote for PAYLEAN 20
How to read a Canadian DIN record